Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2002, Pages

  Barrington, Keith J ^a   Brion, Luc P ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; DOPAMINE; INDOMETACIN; URINARY TRACT AGENT;

CHEMICALLY INDUCED DISORDER; HUMAN; KIDNEY FAILURE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; REVIEW;

CARDIOVASCULAR AGENTS; DOPAMINE; DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY FAILURE; RENAL AGENTS;

EID: 84921623149     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003213     Document Type: Review

References (32)

1. Baenziger O, Waldvogel K, Ghelfi D, Arbenz U, Fanconi S. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study. Klinische Padiatrie 1999;211:438-41.
2. Fajardo CA, Whyte RK, Steele BT. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus [see comments]. Journal of Pediatrics 1992;121:771-5.
3. Seri I, Tulassay T, Kiszel J, Csomor S. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus. International Journal of Pediatric Nephrology 1984;5:209-14.
4. Seri I, Hajdu J, Kiszel J, Tulassay T, Aperia A. Effect of low-dose dopamine infusion on urinary prostaglandin E2 excretion in sick, preterm infants. European Journal of Pediatrics 1988;147:616-20.
5. Tulassay T, Seri I, Machay T, Kiszel J, Varga J, Csomor S. Effects of dopamine on renal functions in premature neonates with respiratory distress syndrome. International Journal of Pediatric Nephrology 1983;4:19-23.
6. Alpan G, Eyal F, Vinograd I, Udassin R, Amir G, Mogle P, Glick B. Localized intestinal perforations after enteral administration of indomethacin in premature infants. Journal of Pediatrics 1985;106:277-81.
7. Barrington KJ, Fox M. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus. American Journal of Perinatology 1994;11:220-2.
8. Bergamo RR, Cominelli F, Kopple JD, Zipser RD. Comparative acute effects of aspirin, diflunisal, ibuprofen and indomethacin on renal function in healthy man. American Journal of Nephrology 1989;9:460-3.
9. Brion LP, Campbell DE. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants (Cochrane Review). Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD001148]
10. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV. Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatric Research 1991;30:106-11.
11. Cheung PY, Barrington KJ. Renal dopamine receptors: mechanisms of action and developmental aspects. Cardiovascular Research 1996;31:2-6.
12. Cifuentes RF, Olley PM, Balfe JW, Radde IC, Soldin SJ. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 1979;95:583-7.
13. Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. Journal of Pediatrics 1996;128:601-7.
14. Corazza MS, Davis RF, Merritt TA, Bejar R, Cvetnic W. Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus. Journal of Pediatrics 1984;105:292-6.
15. Fowlie PW. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 1997, Issue 3. [DOI: 10.1002/14651858.CD000174]
16. Goldberg LI. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacological Reviews 1972;24:1-29.
17. Kellum JA, M Decker J. Use of dopamine in acute renal failure: a meta-analysis. Critical Care Medicine 2001;29:1526-31.
18. Kuhl G, Wille L, Bolkenius M, Seyberth HW. Intestinal perforation associated with indomethacin treatment in premature infants. European Journal of Pediatrics 1985;143:213-6.
19. Manoogian C, Nadler J, Ehrlich L, Horton R. The renal vasodilating effect of dopamine is mediated by calcium flux and prostacyclin release in man. Journal of Clinical Endocrinology and Metabolism 1988;66:678-83.
20. McCrory C, Cunningham J. Low-dose dopamine: will there ever be a scientific rationale?. British Journal of Anaesthesia 1997;78:350-1.
21. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1997;131:549-54.
22. Nehgme RA, O'Connor TZ, Lister G, Bracken MB. Patent Ductus Arteriosus. In: Sinclair JC, Bracken MB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992.
23. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135:733-8.
24. Prins I, Plotz FB, Uiterwaal CS, van Vught HJ. Low-dose dopamine in neonatal and pediatric intensive care: a systematic review. Intensive Care Med 2001;27:206-10.
25. Smith WL, DeWitt DL. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Seminars in Nephrology 1995;15:179-94.
26. Speziale MV, Allen RG, Henderson CR, Barrington KJ, Finer NN. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biology of the Neonate 1999;76:242-52.
27. Thompson BT, Cockrill BA. Renal-dose dopamine: A siren song?. Lancet 1994;344:7-8. [MEDLINE: 146]
28. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Critical Care Medicine 1996;24:1580-90.
29. Van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: Influences of gestational age and disease. Pediatr Res 1997;42:604-9.
30. Van Wassenaer AG, Kok JH, Briet JM, Pijning AM, deVijlder JJM. Thyroid function in very preterm newborns: Possible implications. Thyroid 1999;9:85-91.
31. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Advances in Experimental Medicine and Biology 1997;433:131-8.
32. Barrington KJ, Brion LP. versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003213]